Tumors

DSG-PEG2000-APRPG (DSG-PEG2000-Mal-Cys-APRPG) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an APRPG peptide as a terminal targeting/functional ligand. DSG-PEG2000-APRPG can be used in research on tumor angiogenesis-targeted drug delivery.

DMG-PEG2000-KAA (DMG-PEG2000-Mal-CKAAKNK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a KAA peptide as a terminal targeting/functional ligand. DMG-PEG2000-KAA can be used in research on targeted drug delivery for pancreatic tumors.

DSG-PEG2000-KAA (DSG-PEG2000-Mal-CKAAKNK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a KAA peptide as a terminal targeting/functional ligand. DSG-PEG2000-KAA can be used in research on targeted drug delivery for pancreatic tumors.

DSG-PEG2000-CTT2 is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and the CTT2 peptide as a terminal targeting/functional ligand. DSG-PEG2000-CTT2 can be used in research on targeted drug delivery to the tumor microenvironment.

DMG-PEG2000-F3 (DMG-PEG2000-Mal-Cys-KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an F3 (HY-P10997) peptide as a terminal targeting/functional ligand. DMG-PEG2000-F3 can be used in research such as tumor-targeted drug delivery.

DSG-PEG2000-TAASGVRSMH (DSG-PEG2000-Mal-Cys-TAASGVRSMH) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and the TAASGVRSMH (HY-P10989) peptide as a terminal targeting/functional ligand. DSG-PEG2000-TAASGVRSMH can be used in research on tumor-targeted drug delivery, among other applications.

DSG-PEG2000-NYZL1 (DSG-PEG2000-Mal-Cys-NYZL1) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and the NYZL1 peptide as a terminal targeting/functional ligand. DSG-PEG2000-NYZL1 can be used in research on targeted drug delivery for bladder cancer, among other applications.

DSG-PEG2000-VHPKQHRGGSKGC is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a VHPKQHRGGSKGC (HY-P11088A) peptide as a terminal targeting/functional ligand. DSG-PEG2000-VHPKQHRGGSKGC can be used in research on targeted drug delivery in inflammation, tumor angiogenesis, and atherosclerosis.

DSG-PEG2000-CGKRK (DSG-PEG2000-Mal-Cys-CGKRK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CGKRK peptide as a terminal targeting/functional ligand. DSG-PEG2000-CGKRK can be used in research on tumor angiogenesis-targeted drug delivery, among other applications.

DSG-PEG2000-ESBP (DSG-PEG2000-Mal-Cys-DITWDQLWDLMK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an ESBP peptide as a terminal targeting/functional ligand. DSG-PEG2000-ESBP can be used in research such as targeted drug delivery for inflammation.

DMG-PEG2000-TH (DMG-PEG2000-Mal-Cys-TH) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a TH peptide as a terminal targeting/functional ligand. DMG-PEG2000-TH can be used in studies of tumor microenvironment-responsive drug delivery.

DSG-PEG2000-A7R (DSG-PEG2000-Mal-Cys-ATWLPPR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an A7R (HY-P1663) peptide as a terminal targeting/functional ligand. DSG-PEG2000-A7R can be used in research on tumor angiogenesis-targeted drug delivery, among other applications.

DMG-PEG2000-ANG (DMG-PEG2000-Mal-Cys-TFFYGGSRGKRNNFKTEEY) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an ANG (Angiopep-2) (HY-P2341) peptide as a terminal targeting/functional ligand. DMG-PEG2000-ANG can be used in research such as brain-targeted drug delivery.

DSG-PEG2000-ANG (DSG-PEG2000-Mal-Cys-TFFYGGSRGKRNNFKTEEY) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an ANG (Angiopep-2) (HY-P2341) peptide as a terminal targeting/functional ligand. DSG-PEG2000-ANG can be used in research such as brain-targeted drug delivery.

DMG-PEG2000-YIGSR (DMG-PEG2000-Mal-Cys-YIGSR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a YIGSR (HY-P0132) peptide as a terminal targeting/functional ligand. DMG-PEG2000-YIGSR can be used in research such as tumor-targeted drug delivery.

DMG-PEG2000-TAASGVRSMH (DMG-PEG2000-Mal-Cys-TAASGVRSMH) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and the TAASGVRSMH (HY-P10989) peptide as a terminal targeting/functional ligand. DMG-PEG2000-TAASGVRSMH can be used in research on tumor-targeted drug delivery, among other applications.

DSG-PEG2000-CREKA (DSG-PEG2000-Mal-Cys-CREKA) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CREKA (HY-P10709) peptide as a terminal targeting/functional ligand. DSG-PEG2000-CREKA can be used in research on tumor angiogenesis-targeted drug delivery, among other applications.

DMG-PEG2000-A7R (DMG-PEG2000-Mal-Cys-ATWLPPR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an A7R (HY-P1663) peptide as a terminal targeting/functional ligand. DMG-PEG2000-A7R can be used in research such as tumor angiogenesis-targeted drug delivery.

DSG-PEG2000-BR2 (DSG-PEG2000-Mal-Cys-RAGLQFPVGRLLRRLLR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a BR2 peptide as a terminal targeting/functional ligand. DSG-PEG2000-BR2 can be used in research on targeted drug delivery for breast cancer.

DSG-PEG2000-SP94 (DSG-PEG2000-Mal-Cys-SP94) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an SP94 (HY-P11050A) peptide as a terminal targeting/functional ligand. DSG-PEG2000-SP94 can be used in research on targeted drug delivery for hepatocellular carcinoma.